- Home
- SSB vs MDGL Comparison
SSB vs MDGL Comparison
Compare SSB & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSB | MDGL |
|---|---|---|
| Founded | 1933 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 11.1B |
| IPO Year | 2008 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SSB | MDGL |
|---|---|---|
| Price | $99.73 | $518.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | $118.00 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 649.9K | 262.7K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | 12.91 | ★ 41.32 |
| EPS | ★ 2.28 | N/A |
| Revenue | N/A | ★ $180,133,000.00 |
| Revenue This Year | $10.07 | $58.39 |
| Revenue Next Year | $6.51 | $48.55 |
| P/E Ratio | $43.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $84.48 | $284.02 |
| 52 Week High | $108.46 | $615.00 |
Technical Indicators
Market Signals| Indicator | SSB | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 62.16 | 59.13 |
| Support Level | $98.20 | $498.59 |
| Resistance Level | $99.88 | $540.72 |
| Average True Range (ATR) | 1.86 | 16.82 |
| MACD | 0.38 | 4.78 |
| Stochastic Oscillator | 93.98 | 89.02 |
Price Performance
Historical ComparisonAbout SSB SouthState Corporation
SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time, and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.